Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29051 - 29075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	ELOVL6	79071	downregulated	Dasatinib results in decreased expression of ELOVL6 mRNA	4q25	A21899
Dasatinib	Approved Investigational	ENPP1	5167	downregulated	Dasatinib results in decreased expression of ENPP1 mRNA	6q23.2	A21899
Dasatinib	Approved Investigational	EPAS1	2034	upregulated	Dasatinib results in increased expression of EPAS1 mRNA	2p21	A21899
Dasatinib	Approved Investigational	EPHX1	2052	upregulated	Dasatinib results in increased expression of EPHX1 mRNA	1q42.12	A21899
Dasatinib	Approved Investigational	EXO1	9156	downregulated	Dasatinib results in decreased expression of EXO1 mRNA	1q43	A21899
Dasatinib	Approved Investigational	EZH2	2146	downregulated	Dasatinib results in decreased expression of EZH2 mRNA	7q36.1	A21899
Dasatinib	Approved Investigational	FAM111B	374393	downregulated	Dasatinib results in decreased expression of FAM111B mRNA	11q12.1	A21899
Dasatinib	Approved Investigational	FAM180A	389558	downregulated	Dasatinib results in decreased expression of FAM180A mRNA	7q33	A21899
Dasatinib	Approved Investigational	FAM198B	51313	upregulated	Dasatinib results in increased expression of FAM198B mRNA	4q32.1	A21899
Dasatinib	Approved Investigational	FAM72D	728833	downregulated	Dasatinib results in decreased expression of FAM72D mRNA	1q21.1	A21899
Dasatinib	Approved Investigational	FANCA	2175	downregulated	Dasatinib results in decreased expression of FANCA mRNA	16q24.3	A21899
Dasatinib	Approved Investigational	FANCD2	2177	downregulated	Dasatinib results in decreased expression of FANCD2 mRNA	3p25.3	A21899
Dasatinib	Approved Investigational	FANCI	55215	downregulated	Dasatinib results in decreased expression of FANCI mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	FANCM	57697	downregulated	Dasatinib results in decreased expression of FANCM mRNA	14q21.2	A21899
Dasatinib	Approved Investigational	FBLN5	10516	upregulated	Dasatinib results in increased expression of FBLN5 mRNA	14q32.12	A21899
Dasatinib	Approved Investigational	FBXO32	114907	upregulated	Dasatinib results in increased expression of FBXO32 mRNA	8q24.13	A21899
Dasatinib	Approved Investigational	FBXO5	26271	downregulated	Dasatinib results in decreased expression of FBXO5 mRNA	6q25.2	A21899
Dasatinib	Approved Investigational	FEN1	2237	downregulated	Dasatinib results in decreased expression of FEN1 mRNA	11q12.2	A21899
Dasatinib	Approved Investigational	FGF5	2250	downregulated	Dasatinib results in decreased expression of FGF5 mRNA	4q21.21	A21899
Dasatinib	Approved Investigational	FGF9	2254	upregulated	Dasatinib results in increased expression of FGF9 mRNA	13q12.11	A21899
Dasatinib	Approved Investigational	FGL2	10875	upregulated	Dasatinib results in increased expression of FGL2 mRNA	7q11.23	A21899
Dasatinib	Approved Investigational	FHL1	2273	upregulated	Dasatinib results in increased expression of FHL1 mRNA	Xq26.3	A21899
Dasatinib	Approved Investigational	FIGNL1	63979	downregulated	Dasatinib results in decreased expression of FIGNL1 mRNA	7p12.2	A21899
Dasatinib	Approved Investigational	FOXM1	2305	downregulated	Dasatinib results in decreased expression of FOXM1 mRNA	12p13.33	A21899
Dasatinib	Approved Investigational	G0S2	50486	downregulated	Dasatinib results in decreased expression of G0S2 mRNA	1q32.2	A21899

Displaying entries 29051 - 29075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability